Escalating Keratinocyte Cancer Burden: Aspirin Emerges as Potential Chemopreventive Agent

Strategic Insights -

Keratinocyte cancer is a growing concern, particularly among older Australian adults, where the incidence has been found to be significantly higher compared to younger individuals. According to recent research from Monash University, the burden of keratinocyte cancers is not only straining the medical system but also amplifying patient morbidity and mortality. The study highlights the urgent need for efficacious and safe chemoprevention agents, with aspirin emerging as a potential solution.

Key Takeaways:

  • The incidence of keratinocyte cancer in older Australian adults (80-84 years) is 6,000/100,000 per year, compared to 26/100,000 in individuals aged 20-24 years.
  • Keratinocyte cancers account for 25% of all cancer-related hospitalizations and $1 billion in treatment costs per year in Australia.
  • Those immunosuppressed, with haematological malignancy or solid organ transplant, are at highest risk of developing keratinocyte cancer.
  • Older adults and UV-exposed Caucasian populations are increasingly requiring treatment for multiple keratinocyte cancers each year.
  • Aspirin has been investigated as a chemopreventive agent for several years in other cancers.
  • The study highlights the need for efficacious, tolerable, and safe chemoprevention agents to decrease keratinocyte cancer burden.
  • Aspirin has emerged as a potential solution to this problem, with its role in chemopreventing keratinocyte cancers discussed in the study.
  • The study has been peer-reviewed and published in the Journal of Cancer Prevention.

Statistics:

  • 6,000/100,000: Incidence of keratinocyte cancer in older Australian adults (80-84 years) per year.
  • 26/100,000: Incidence of keratinocyte cancer in individuals aged 20-24 years per year.
  • 25%: Proportion of cancer-related hospitalizations accounted for by keratinocyte cancers in Australia.
  • $1 billion: Estimated annual treatment costs for keratinocyte cancers in Australia.
  • 2011-2014: Time period of data collection for keratinocyte cancer incidence in Queensland, Australia.

Sources:

  • NewsRx. Monash University Reports Findings in Cancer (Chemoprevention of Keratinocyte Cancers: Could Aspirin Be the Solution?). Chemicals & Chemistry. July 25, 2025; p 1866.
  • Chemoprevention of Keratinocyte Cancers: Could Aspirin Be the Solution? Journal of Cancer Prevention, 2025;30(2):59-74.